Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia

Giuseppe d'Annunzio; Claudio Maffeis; Valentino Cherubini; Ivana Rabbone; Andrea Scaramuzza; Riccardo Schiaffini; Nicola Minuto; Gianluca Piccolo; Mohamad Maghnie

doi:10.1016/j.diabres.2020.108372

Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia

Giuseppe d'Annunzio, Claudio Maffeis, Valentino Cherubini, Ivana Rabbone, Andrea Scaramuzza, Riccardo Schiaffini, Nicola Minuto, Gianluca Piccolo, Mohamad Maghnie

Research output: Contribution to journal › Review article › peer-review

Abstract

AIMS: Our study aimed to review the impact of COVID-19 pandemia in children and adolescents with type 1 diabetes mellitus, to analyze the clinical characteristics of the infection and to propose clinical practice recommendations from the Italian Society for Pediatric Endocrinology and Diabetology (ISPED).

METHODS: A literature search was carried out in the guideline databases, Medline and Embase and in Diabetes Societies websites until May 21st, 2020 for guidelines and recommendations on type 1 diabetes mellitus management during COVID-19 pandemic.

RESULTS: COVID-19 infection in pediatric patients seems to be clinically less severe than in adults; children have so far accounted for 1-5% of diagnosed cases, with a median age of 6.7 years (1 day-15 years) and better prognosis. Clinical manifestations include mild, moderate, severe disease up to critical illness. There is currently no evidence suggesting a higher risk of COVID-19 infection in children with diabetes than unaffected peers. Besides general recommendations for pediatric patients, ISPED has proposed specific measures for patients with diabetes.

CONCLUSION: COVID-19 outbreak modified type 1 diabetes management, and telemedicine has been demonstrating to be an effective new tool for patients care. Moreover psychological aspects deserve attention and future researchs are mandatory.

Original language	English
Pages (from-to)	108372
Journal	Diabetes Research and Clinical Practice
Volume	168
DOIs	https://doi.org/10.1016/j.diabres.2020.108372
Publication status	Published - Oct 2020

Keywords

Adolescent
Age of Onset
Betacoronavirus
COVID-19
Child
Child, Preschool
Coronavirus Infections/epidemiology
Diabetes Mellitus, Type 1/epidemiology
Endocrinology/organization & administration
Female
Humans
Infant
Infant, Newborn
Italy/epidemiology
Male
Pandemics
Pneumonia, Viral/epidemiology
SARS-CoV-2
Societies, Medical
Telemedicine/organization & administration

Access to Document

10.1016/j.diabres.2020.108372

Fingerprint Dive into the research topics of 'Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia'. Together they form a unique fingerprint.

Cite this

d'Annunzio, G., Maffeis, C., Cherubini, V., Rabbone, I., Scaramuzza, A., Schiaffini, R., Minuto, N., Piccolo, G., & Maghnie, M. (2020). Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia. Diabetes Research and Clinical Practice, 168, 108372. https://doi.org/10.1016/j.diabres.2020.108372

Caring for children and adolescents with type 1 diabetes mellitus : Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia. / d'Annunzio, Giuseppe; Maffeis, Claudio; Cherubini, Valentino; Rabbone, Ivana; Scaramuzza, Andrea; Schiaffini, Riccardo ; Minuto, Nicola; Piccolo, Gianluca; Maghnie, Mohamad.

In: Diabetes Research and Clinical Practice, Vol. 168, 10.2020, p. 108372.

Research output: Contribution to journal › Review article › peer-review

d'Annunzio, G, Maffeis, C, Cherubini, V, Rabbone, I, Scaramuzza, A, Schiaffini, R , Minuto, N, Piccolo, G & Maghnie, M 2020, 'Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia', Diabetes Research and Clinical Practice, vol. 168, pp. 108372. https://doi.org/10.1016/j.diabres.2020.108372

d'Annunzio, Giuseppe ; Maffeis, Claudio ; Cherubini, Valentino ; Rabbone, Ivana ; Scaramuzza, Andrea ; Schiaffini, Riccardo ; Minuto, Nicola ; Piccolo, Gianluca ; Maghnie, Mohamad. / Caring for children and adolescents with type 1 diabetes mellitus : Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia. In: Diabetes Research and Clinical Practice. 2020 ; Vol. 168. pp. 108372.

@article{e6f8850479204d138723b0cea1ab8ee7,

title = "Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia",

abstract = "AIMS: Our study aimed to review the impact of COVID-19 pandemia in children and adolescents with type 1 diabetes mellitus, to analyze the clinical characteristics of the infection and to propose clinical practice recommendations from the Italian Society for Pediatric Endocrinology and Diabetology (ISPED).METHODS: A literature search was carried out in the guideline databases, Medline and Embase and in Diabetes Societies websites until May 21st, 2020 for guidelines and recommendations on type 1 diabetes mellitus management during COVID-19 pandemic.RESULTS: COVID-19 infection in pediatric patients seems to be clinically less severe than in adults; children have so far accounted for 1-5% of diagnosed cases, with a median age of 6.7 years (1 day-15 years) and better prognosis. Clinical manifestations include mild, moderate, severe disease up to critical illness. There is currently no evidence suggesting a higher risk of COVID-19 infection in children with diabetes than unaffected peers. Besides general recommendations for pediatric patients, ISPED has proposed specific measures for patients with diabetes.CONCLUSION: COVID-19 outbreak modified type 1 diabetes management, and telemedicine has been demonstrating to be an effective new tool for patients care. Moreover psychological aspects deserve attention and future researchs are mandatory.",

keywords = "Adolescent, Age of Onset, Betacoronavirus, COVID-19, Child, Child, Preschool, Coronavirus Infections/epidemiology, Diabetes Mellitus, Type 1/epidemiology, Endocrinology/organization & administration, Female, Humans, Infant, Infant, Newborn, Italy/epidemiology, Male, Pandemics, Pneumonia, Viral/epidemiology, SARS-CoV-2, Societies, Medical, Telemedicine/organization & administration",

author = "Giuseppe d'Annunzio and Claudio Maffeis and Valentino Cherubini and Ivana Rabbone and Andrea Scaramuzza and Riccardo Schiaffini and Nicola Minuto and Gianluca Piccolo and Mohamad Maghnie",

note = "Copyright {\textcopyright} 2020. Published by Elsevier B.V.",

year = "2020",

month = oct,

doi = "10.1016/j.diabres.2020.108372",

language = "English",

volume = "168",

pages = "108372",

journal = "Diabetes Research and Clinical Practice",

issn = "0168-8227",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Caring for children and adolescents with type 1 diabetes mellitus

T2 - Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia

AU - d'Annunzio, Giuseppe

AU - Maffeis, Claudio

AU - Cherubini, Valentino

AU - Rabbone, Ivana

AU - Scaramuzza, Andrea

AU - Schiaffini, Riccardo

AU - Minuto, Nicola

AU - Piccolo, Gianluca

AU - Maghnie, Mohamad

PY - 2020/10

Y1 - 2020/10

N2 - AIMS: Our study aimed to review the impact of COVID-19 pandemia in children and adolescents with type 1 diabetes mellitus, to analyze the clinical characteristics of the infection and to propose clinical practice recommendations from the Italian Society for Pediatric Endocrinology and Diabetology (ISPED).METHODS: A literature search was carried out in the guideline databases, Medline and Embase and in Diabetes Societies websites until May 21st, 2020 for guidelines and recommendations on type 1 diabetes mellitus management during COVID-19 pandemic.RESULTS: COVID-19 infection in pediatric patients seems to be clinically less severe than in adults; children have so far accounted for 1-5% of diagnosed cases, with a median age of 6.7 years (1 day-15 years) and better prognosis. Clinical manifestations include mild, moderate, severe disease up to critical illness. There is currently no evidence suggesting a higher risk of COVID-19 infection in children with diabetes than unaffected peers. Besides general recommendations for pediatric patients, ISPED has proposed specific measures for patients with diabetes.CONCLUSION: COVID-19 outbreak modified type 1 diabetes management, and telemedicine has been demonstrating to be an effective new tool for patients care. Moreover psychological aspects deserve attention and future researchs are mandatory.

AB - AIMS: Our study aimed to review the impact of COVID-19 pandemia in children and adolescents with type 1 diabetes mellitus, to analyze the clinical characteristics of the infection and to propose clinical practice recommendations from the Italian Society for Pediatric Endocrinology and Diabetology (ISPED).METHODS: A literature search was carried out in the guideline databases, Medline and Embase and in Diabetes Societies websites until May 21st, 2020 for guidelines and recommendations on type 1 diabetes mellitus management during COVID-19 pandemic.RESULTS: COVID-19 infection in pediatric patients seems to be clinically less severe than in adults; children have so far accounted for 1-5% of diagnosed cases, with a median age of 6.7 years (1 day-15 years) and better prognosis. Clinical manifestations include mild, moderate, severe disease up to critical illness. There is currently no evidence suggesting a higher risk of COVID-19 infection in children with diabetes than unaffected peers. Besides general recommendations for pediatric patients, ISPED has proposed specific measures for patients with diabetes.CONCLUSION: COVID-19 outbreak modified type 1 diabetes management, and telemedicine has been demonstrating to be an effective new tool for patients care. Moreover psychological aspects deserve attention and future researchs are mandatory.

KW - Adolescent

KW - Age of Onset

KW - Betacoronavirus

KW - COVID-19

KW - Child

KW - Child, Preschool

KW - Coronavirus Infections/epidemiology

KW - Diabetes Mellitus, Type 1/epidemiology

KW - Endocrinology/organization & administration

KW - Female

KW - Humans

KW - Infant

KW - Infant, Newborn

KW - Italy/epidemiology

KW - Male

KW - Pandemics

KW - Pneumonia, Viral/epidemiology

KW - SARS-CoV-2

KW - Societies, Medical

KW - Telemedicine/organization & administration

U2 - 10.1016/j.diabres.2020.108372

DO - 10.1016/j.diabres.2020.108372

M3 - Review article

C2 - 32827594

VL - 168

SP - 108372

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

ER -